QuickSearch:    by PDB,NDB,UniProt,PROSITE Code or Search Term(s)

   Search term(s): GO:0002706

Here you see a subgraph of the complete GO graph, with your query GO:0002706 as the highest hiearchical level and all levels of lower hierarchy. The number of PDB entries, for which a UniProt entry annotated with the corresponding GO term is available, is shown in square brackets for all hiearchical levels of the subgraph.

• regulation of lymphocyte mediated immunity (GO:0002706)
  • negative regulation of lymphocyte mediated immunity (GO:0002707)
    • negative regulation of B cell mediated immunity (GO:0002713)
      • negative regulation of B cell antigen processing and presentation (GO:0002623)
      • negative regulation of B cell cytokine production (GO:0002722)
      • negative regulation of immunoglobulin mediated immune response (GO:0002890)
      • negative regulation of peripheral B cell anergy (GO:0002918)
      • negative regulation of peripheral B cell deletion (GO:0002909)
    • negative regulation of natural killer cell mediated immunity (GO:0002716)
      • negative regulation of natural killer cell cytokine production (GO:0002728)
      • negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)
        [39 PDB entries]
        
        
      • negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)
    • negative regulation of T cell mediated immunity (GO:0002710)
      [2 PDB entries]
      
      
    • negative regulation of peripheral T cell tolerance induction (GO:0002850)
    • negative regulation of T cell antigen processing and presentation (GO:0002626)
      [3 PDB entries]
      
      
    • negative regulation of T cell cytokine production (GO:0002725)
      [22 PDB entries]
      
      
    • negative regulation of T cell mediated cytotoxicity (GO:0001915)
      [32 PDB entries]
      
      
    • negative regulation of T cell mediated immune response to tumor cell (GO:0002841)
    • negative regulation of type IV hypersensitivity (GO:0001808)
      [2 PDB entries]
      
      
  • positive regulation of lymphocyte mediated immunity (GO:0002708)
    • positive regulation of B cell mediated immunity (GO:0002714)
      • helper T cell enhancement of B cell mediated immune response (GO:0035399)
      • positive regulation of B cell antigen processing and presentation (GO:0002624)
      • positive regulation of B cell cytokine production (GO:0002723)
      • positive regulation of immunoglobulin mediated immune response (GO:0002891)
        [11 PDB entries]
        
        
      • positive regulation of peripheral B cell anergy (GO:0002919)
      • positive regulation of peripheral B cell deletion (GO:0002910)
    • positive regulation of natural killer cell mediated immunity (GO:0002717)
      [12 PDB entries]
      
      
    • positive regulation of natural killer cell cytokine production (GO:0002729)
    • positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)
      [68 PDB entries]
      
      
    • positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)
    • positive regulation of T cell mediated immunity (GO:0002711)
      [32 PDB entries]
      
      
    • helper T cell enhancement of T cell mediated immune response (GO:0035398)
    • positive regulation of peripheral T cell tolerance induction (GO:0002851)
      [3 PDB entries]
      
      
    • positive regulation of T cell antigen processing and presentation (GO:0002627)
    • positive regulation of T cell cytokine production (GO:0002726)
      [976 PDB entries]
      
      
    • positive regulation of T cell mediated cytotoxicity (GO:0001916)
      [952 PDB entries]
      
      
    • positive regulation of T cell mediated immune response to tumor cell (GO:0002842)
      [1 PDB entries]
      
      
    • positive regulation of type IV hypersensitivity (GO:0001809)
      [3 PDB entries]
      
      
  • regulation of B cell mediated immunity (GO:0002712)
    • negative regulation of B cell mediated immunity (GO:0002713)
      • negative regulation of B cell antigen processing and presentation (GO:0002623)
      • negative regulation of B cell cytokine production (GO:0002722)
      • negative regulation of immunoglobulin mediated immune response (GO:0002890)
      • negative regulation of peripheral B cell anergy (GO:0002918)
      • negative regulation of peripheral B cell deletion (GO:0002909)
    • positive regulation of B cell mediated immunity (GO:0002714)
      • helper T cell enhancement of B cell mediated immune response (GO:0035399)
      • positive regulation of B cell antigen processing and presentation (GO:0002624)
      • positive regulation of B cell cytokine production (GO:0002723)
      • positive regulation of immunoglobulin mediated immune response (GO:0002891)
        [11 PDB entries]
        
        
      • positive regulation of peripheral B cell anergy (GO:0002919)
      • positive regulation of peripheral B cell deletion (GO:0002910)
    • regulation of B cell antigen processing and presentation (GO:0002622)
      • negative regulation of B cell antigen processing and presentation (GO:0002623)
      • positive regulation of B cell antigen processing and presentation (GO:0002624)
    • regulation of B cell cytokine production (GO:0002721)
      [52 PDB entries]
      
      
    • negative regulation of B cell cytokine production (GO:0002722)
    • positive regulation of B cell cytokine production (GO:0002723)
    • regulation of immunoglobulin mediated immune response (GO:0002889)
      • negative regulation of immunoglobulin mediated immune response (GO:0002890)
      • positive regulation of immunoglobulin mediated immune response (GO:0002891)
        [11 PDB entries]
        
        
      • regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)
      • regulation of immunoglobulin production in mucosal tissue (GO:2000557)
      • regulation of isotype switching (GO:0045191)
        [40 PDB entries]
        
        
      • regulation of type I hypersensitivity (GO:0001810)
      • regulation of type II hypersensitivity (GO:0002892)
      • regulation of type III hypersensitivity (GO:0001803)
    • regulation of peripheral B cell anergy (GO:0002917)
      • negative regulation of peripheral B cell anergy (GO:0002918)
      • positive regulation of peripheral B cell anergy (GO:0002919)
    • regulation of peripheral B cell deletion (GO:0002908)
      • negative regulation of peripheral B cell deletion (GO:0002909)
      • positive regulation of peripheral B cell deletion (GO:0002910)
  • regulation of natural killer cell mediated immunity (GO:0002715)
    [10 PDB entries]
    
    
  • negative regulation of natural killer cell mediated immunity (GO:0002716)
    • negative regulation of natural killer cell cytokine production (GO:0002728)
    • negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)
      [39 PDB entries]
      
      
    • negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)
  • positive regulation of natural killer cell mediated immunity (GO:0002717)
    [12 PDB entries]
    
    
  • positive regulation of natural killer cell cytokine production (GO:0002729)
  • positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)
    [68 PDB entries]
    
    
  • positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)
  • regulation of natural killer cell cytokine production (GO:0002727)
    • negative regulation of natural killer cell cytokine production (GO:0002728)
    • positive regulation of natural killer cell cytokine production (GO:0002729)
  • regulation of natural killer cell mediated cytotoxicity (GO:0042269)
    [4 PDB entries]
    
    
  • negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)
    [39 PDB entries]
    
    
  • positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)
    [68 PDB entries]
    
    
  • regulation of natural killer cell degranulation (GO:0043321)
  • regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)
  • regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)
    • negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)
    • positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)
    • regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)
  • regulation of T cell mediated immunity (GO:0002709)
    [8 PDB entries]
    
    
  • negative regulation of T cell mediated immunity (GO:0002710)
    [2 PDB entries]
    
    
  • negative regulation of peripheral T cell tolerance induction (GO:0002850)
  • negative regulation of T cell antigen processing and presentation (GO:0002626)
    [3 PDB entries]
    
    
  • negative regulation of T cell cytokine production (GO:0002725)
    [22 PDB entries]
    
    
  • negative regulation of T cell mediated cytotoxicity (GO:0001915)
    [32 PDB entries]
    
    
  • negative regulation of T cell mediated immune response to tumor cell (GO:0002841)
  • negative regulation of type IV hypersensitivity (GO:0001808)
    [2 PDB entries]
    
    
  • positive regulation of T cell mediated immunity (GO:0002711)
    [32 PDB entries]
    
    
  • helper T cell enhancement of T cell mediated immune response (GO:0035398)
  • positive regulation of peripheral T cell tolerance induction (GO:0002851)
    [3 PDB entries]
    
    
  • positive regulation of T cell antigen processing and presentation (GO:0002627)
  • positive regulation of T cell cytokine production (GO:0002726)
    [976 PDB entries]
    
    
  • positive regulation of T cell mediated cytotoxicity (GO:0001916)
    [952 PDB entries]
    
    
  • positive regulation of T cell mediated immune response to tumor cell (GO:0002842)
    [1 PDB entries]
    
    
  • positive regulation of type IV hypersensitivity (GO:0001809)
    [3 PDB entries]
    
    
  • regulation of peripheral T cell tolerance induction (GO:0002849)
    • negative regulation of peripheral T cell tolerance induction (GO:0002850)
    • positive regulation of peripheral T cell tolerance induction (GO:0002851)
      [3 PDB entries]
      
      
    • regulation of T cell tolerance induction to tumor cell (GO:0002846)
  • regulation of T cell antigen processing and presentation (GO:0002625)
    [6 PDB entries]
    
    
  • negative regulation of T cell antigen processing and presentation (GO:0002626)
    [3 PDB entries]
    
    
  • positive regulation of T cell antigen processing and presentation (GO:0002627)
  • regulation of T cell cytokine production (GO:0002724)
    [4 PDB entries]
    
    
  • negative regulation of T cell cytokine production (GO:0002725)
    [22 PDB entries]
    
    
  • positive regulation of T cell cytokine production (GO:0002726)
    [976 PDB entries]
    
    
  • regulation of T-helper 1 cell cytokine production (GO:2000554)
  • regulation of T-helper 2 cell cytokine production (GO:2000551)
  • regulation of T cell mediated cytotoxicity (GO:0001914)
    [25 PDB entries]
    
    
  • negative regulation of T cell mediated cytotoxicity (GO:0001915)
    [32 PDB entries]
    
    
  • positive regulation of T cell mediated cytotoxicity (GO:0001916)
    [952 PDB entries]
    
    
  • regulation of cytotoxic T cell degranulation (GO:0043317)
  • regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852)
  • regulation of T cell mediated immune response to tumor cell (GO:0002840)
    [13 PDB entries]
    
    
  • negative regulation of T cell mediated immune response to tumor cell (GO:0002841)
  • positive regulation of T cell mediated immune response to tumor cell (GO:0002842)
    [1 PDB entries]
    
    
  • regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852)
  • regulation of T cell tolerance induction to tumor cell (GO:0002846)
  • regulation of type IV hypersensitivity (GO:0001807)
    • negative regulation of type IV hypersensitivity (GO:0001808)
      [2 PDB entries]
      
      
    • positive regulation of type IV hypersensitivity (GO:0001809)
      [3 PDB entries]
      
      

Click on the GO accession number to get a tree view of the GO hierarchy without information on PDB entries. In this case your query level and all levels of higher hierarchy up to the root level Gene_Ontology (GO:0003673) are displayed.

If you enter the GO tree somewhere and if you want to get a view of the whole tree first click on the GO name. This yields the low-hierarchy part. Then click on the GO accession number of the lowest hierarchical level. This gives a view of the complete tree. Note, that certain GO terms belong to more than one path.

GO2PDB@JenaLib
Tue Jul 9 10:48:17 2019